3.2 billion base pairs. Longevity AI–interpreted and continuously updated as science advances. The permanent foundation for a longer, healthier life.
of serious disease risk
is influenced by genetics
Most of it is invisible to standard testing.
Risk is written in your DNA long before symptoms appear.
Most tests sample less than 1% of your genome. We analyze all 3.2 billion base pairs.
All 3.2 billion base pairs — not pre-selected regions or a genotyping chip.
30× sequencing depth. Clinical-grade accuracy backed by 50,000+ genomes in HLI's database.
200+ conditions, 200+ medications, and carrier status — interpreted by Longevity AI.
Re-analyzed as science advances. New gene-disease associations applied to your genome automatically.
| Human Longevity | Targeted Panels | Consumer Tests | |
|---|---|---|---|
| Genome coverage | 100% — all 3.2B base pairs | ~0.1% | <0.02% |
| Coverage depth | 30× clinical-grade | Varies | — |
| Hereditary disease risk | 200+ conditions | Panel-specific only | Select conditions |
| Pharmacogenomics | 200+ medications | Rarely included | — |
| Carrier status | 200+ conditions | Panel-dependent | Very limited |
| AI interpretation | Longevity AI clinical review | Varies | — |
| Price | $599 — one time | $300–$5,000+ | $99–$229 |
Four areas.
One test.
2-minute checkout. Kit delivered to your door in 2–3 days. $599, no subscription required.
Simple saliva sample at home. No clinic visit, no blood draw, no referral needed.
CLIA-certified lab sequences your genome. Longevity AI interprets billions of variants against HLI's database of 50,000+ genomes.
Secure portal and app with your full results and Longevity AI insights. Your genome, sequenced once — informative for life.
“Pharmacogenomics showed my genes couldn't metabolize SSRIs. We switched — it worked immediately. I wish I had done this test first.”

“Genomics found my Lynch Syndrome before symptoms. I started screening early — and caught two precancerous polyps. That test gave me a 20-year head start.”

“We learned we were both CF carriers before pregnancy. It completely changed our options. We never would have known without whole genome sequencing.”

“Pharmacogenomics showed my genes couldn't metabolize SSRIs. We switched — it worked immediately. I wish I had done this test first.”

“Genomics found my Lynch Syndrome before symptoms. I started screening early — and caught two precancerous polyps. That test gave me a 20-year head start.”

“We learned we were both CF carriers before pregnancy. It completely changed our options. We never would have known without whole genome sequencing.”


Led by the scientist who sequenced the first human genome, our approach starts where traditional medicine doesn't — at the level where risk begins.
“Sequencing the human genome changed what medicine could see. Now, it's about acting on that information earlier.”
This is where our model of medicine begins.
No subscriptions. No add-ons. No hidden fees.
One-time. No subscription.
HIPAA-compliant · Data never sold

30–50% of medications fail due to genetic variation. Know which drugs will work for your biology before you take them.
Read article →From BRCA1/2 to polygenic heart scores to APOE Alzheimer's risk — what hereditary analysis reveals and why it changes care.
Read article →Everyone carries 2–3 disease-causing variants. Most never know until they have an affected child. Here's what whole genome screening covers.
Read article →